GSK plc reported the purchase of 209,886 of its own shares on September 17, 2025, with prices ranging from 1,461.50p to 1,478.50p, part of an ongoing buyback program. This increases its treasury shares to 247,448,986 out of 4,067,953,982 total shares issued.